Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2881 AL 2895

Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer's Disease

Abou MB, Sun L, Wei H.

Curr Alzheimer Res. 2020;17(4):324-328. doi: 10.2174/1567205017666200522204722.

[Mechanisms of electroacupuncture for improving Alzheimer's disease from reducing β amyloid protein level]

Yang WD, Dong WG.

Zhen Ci Yan Jiu. 2020 May 25;45(5):426-31. doi: 10.13702/j.1000-0607.180885.

A Perspective on Multi-target Drugs for Alzheimer's Disease

Benek O, Korabecny J, Soukup O.

Trends Pharmacol Sci. 2020 Jul;41(7):434-445. doi: 10.1016/j.tips.2020.04.008. Epub 2020 May 21.

Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease

Fülöp T, Munawara U, Larbi A, Desroches M, Rodrigues S, Catanzaro M, Guidolin A, Khalil A, Bernier F, Barron AE, Hirokawa K, Beauregard PB, Dumoulin D, Bellenger JP, Witkowski JM, Frost E.

CNS Drugs. 2020 Jul;34(7):673-695. doi: 10.1007/s40263-020-00737-1.

Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges

Zipfel P, Rochais C, Baranger K, Rivera S, Dallemagne P.

J Med Chem. 2020 Oct 8;63(19):10705-10725. doi: 10.1021/acs.jmedchem.0c00352. Epub 2020 Jun 10.

Editorial: Next-Generation Alzheimer's Therapeutics: Leveraging Deep Biology

Longo FM, Massa SM.

J Prev Alzheimers Dis. 2020;7(3):138-139. doi: 10.14283/jpad.2020.30.

The Role of the Family in the Care of Alzheimer Patients

Xristina F, Demeter K, John G, Maria C.

Adv Exp Med Biol. 2020;1196:103-107. doi: 10.1007/978-3-030-32637-1_10.

Alzheimer's Disease Therapeutic Approaches

Revi M.

Adv Exp Med Biol. 2020;1195:105-116. doi: 10.1007/978-3-030-32633-3_15.

What Do Recent Clinical Trials Teach Us About the Etiology of AD

Robakis NK.

Adv Exp Med Biol. 2020;1195:167. doi: 10.1007/978-3-030-32633-3_23.

Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease

Popugaeva E, Chernyuk D, Bezprozvanny I.

Curr Alzheimer Res. 2020;17(4):344-354. doi: 10.2174/1567205017666200528162046.

Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities

Meng L, Li XY, Shen L, Ji HF.

Trends Mol Med. 2020 Jun;26(6):597-614. doi: 10.1016/j.molmed.2020.02.002. Epub 2020 Mar 23.

Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease

Wilson B, Geetha KM.

J Control Release. 2020 Sep 10;325:25-37. doi: 10.1016/j.jconrel.2020.05.044. Epub 2020 May 28.

A decade of Alzheimer's Research & Therapy: reflections on the past, present, and future

Galasko D, Scheltens P.

Alzheimers Res Ther. 2020 May 30;12(1):67. doi: 10.1186/s13195-020-00629-y.

Assessing an evidence-based intervention for spouse caregivers of persons with Alzheimer's disease: results of a community implementation of the NYUCI in Israel

Werner P, Clay OJ, Goldstein D, Kermel-Schifmann I, Herz MK, Epstein C, Mittelman MS.

Aging Ment Health. 2021 Sep;25(9):1676-1683. doi: 10.1080/13607863.2020.1774740. Epub 2020 Jun 4.

Inter-individual differences in the responses to aerobic exercise in Alzheimer's disease: Findings from the FIT-AD trial

Yu F, Salisbury D, Mathiason MA.

J Sport Health Sci. 2021 Jan;10(1):65-72. doi: 10.1016/j.jshs.2020.05.007. Epub 2020 Jun 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias